JCP Editors

Pathways in Practice

Development and Use of a Pathway for Chronic Lymphocytic Leukemia: The US Oncology Experience

11/18/2019

JCP Editors

*/ /*-->*/ In this journal section, we speak with cancer care practitioners about their clinical pathways and the pathways programs being used in their practice, how they are being applied in a particular...

...

11/18/2019

Journal of Clinical Pathways

Research in Review

11/18/2019

JCP Editors

Improving Treatment Adherence Through a CML Specialty Pharmacy Service Model A two-way clinical messaging platform in a specialty pharmacy service model may positively affect adherence outcomes in patients with...

...

11/18/2019

Journal of Clinical Pathways

Conference Coverage

Clinical Pathways for Ovarian Cancer

11/15/2019

JCP Editors

For ovarian cancer, in which treatment recurrence is a challenge and long-term maintenance therapy is often required, the clinical and financial implications of long-term treatment may differ from those of other...

For...

11/15/2019

Journal of Clinical Pathways

Interview

Pathways in an Evolving Treatment Landscape

11/15/2019

JCP Editors

Clinical pathways are prone to criticisms that they do not take patient diversity or the latest clinical advances into account, both of which can be addressed through comprehensive pathway design and updating...

...

11/15/2019

Journal of Clinical Pathways

Interview

Harnessing the Potential of Real-World Data to Support Clinical Pathways

11/15/2019

JCP Editors

Current clinical pathways are largely based on generalized measures such as evidence-based guidelines and consensus best practices. Yet electronic medical records (EMRs) contain a tremendous amount of data that, when...

...

11/15/2019

Journal of Clinical Pathways

Interview

Individualizing Treatment Within Clinical Pathways for Multiple Myeloma

11/15/2019

JCP Editors

Standardizing treatment options for relapsed/refractory multiple myeloma poses a challenge to clinical pathway decision-makers, due to the need to individualize treatment decisions for the patient’s specific...

...

11/15/2019

Journal of Clinical Pathways

Interview

An Oncology Pathways Pioneer Paves the Way for Pathways Across Medicine

11/15/2019

JCP Editors

In 2012, Dr Barbara L. McAneny was awarded a $19.76 million grant by the Center for Medicare & Medicaid Innovation to develop the Community Oncology Medical Home (COME HOME) model and implement that model in...

In...

11/15/2019

Journal of Clinical Pathways

Conference Coverage

Highlighted Presentations from the 2018 Clinical Pathways Congress

11/15/2019

JCP Editors

Pros and Cons of Vendor- and Provider-Developed Pathways On Day 1 of the 2018 Clinical Pathways Congress, Bobby Daly, MD, MBA, Memorial Sloan Kettering Cancer Center (New York, NY), and Robin T. Zon, MD, FACP,...

Pros...

11/15/2019

Journal of Clinical Pathways

Conference Coverage

2019 Oncology Clinical Pathways Congress

10/18/2019

JCP Editors

Now in its fourth year, the Oncology Clinical Pathways Congress (OCPC) serves as a forum for oncology care professionals interested in utilizing clinical pathways as a tool to facilitate more value-based care...

Now...

10/18/2019

Journal of Clinical Pathways

Conference Coverage

European Society of Medical Oncology Annual Congress 2019

10/18/2019

JCP Editors

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 27.0px Helvetica} p.p2 {margin: 0.0px 0.0px 0.0px 0.0px; text-align: justify; line-height: 12.0px; font: 10.0px Helvetica} p.p3...

p.p1...

10/18/2019

Journal of Clinical Pathways